Ideaya Biosciences Inc (IDYA): Eigentümerstruktur
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Ideaya Biosciences Inc
Mitarbeiter 145
Handelsplatz NASDAQ
Ticker Symbol IDYA
IPO Datum 2019-05-23
Adresse 5000 Shoreline Court, South San Francisco, CA, United States, 94080
Webseite https://www.ideayabio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Yujiro S. Hata | Founder, President, CEO & Chairman |
| 2 | Dr. Joshua Bleharski M.B.A., Ph.D. | Chief Financial Officer |
| 3 | Mr. Andres Ruiz Briseno CPA | Chief Accounting Officer |
| 4 | Dr. Michael A. White Ph.D. | Chief Scientific Officer |
| 5 | Mr. Douglas B. Snyder | Chief Legal Officer |
| 6 | Dr. Darrin M. Beaupre M.D., Ph.D. | Chief Medical Officer |
| 7 | Dr. Paul A. Barsanti Ph.D. | Chief Technology Officer |
| 8 | Ms. Francine Zelaya | Senior VP & Head of Human Resources |
| 9 | Mr. Mick O'Quigley | Senior Vice President of Medical Writing & Project Management |
| 10 | Mr. Daniel A. Simon | Chief Business Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 13,65% | 0,50 Mrd. USD |
| 2 | BlackRock Inc | 8,75% | 0,32 Mrd. USD |
| 3 | HHG PLC | 7,53% | 0,27 Mrd. USD |
| 4 | Capital Research Global Investors | 5,54% | 0,20 Mrd. USD |
| 5 | Baker Bros Advisors LP | 4,09% | 0,15 Mrd. USD |
| 6 | State Street Corp | 3,92% | 0,14 Mrd. USD |
| 7 | Vanguard Capital Management, LLC | 3,87% | 0,14 Mrd. USD |
| 8 | Logos Global Management LP | 3,11% | 0,11 Mrd. USD |
| 9 | Adage Capital Partners Gp LLC | 2,81% | 0,10 Mrd. USD |
| 10 | Fiera Capital Corporation | 2,62% | 0,10 Mrd. USD |
| 11 | Geode Capital Management, LLC | 2,59% | 0,09 Mrd. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 1,93% | 0,07 Mrd. USD |
| 13 | Dimensional Fund Advisors, Inc. | 1,72% | 0,06 Mrd. USD |
| 14 | The Goldman Sachs Group Inc | 1,72% | 0,06 Mrd. USD |
| 15 | Deerfield Management Co | 1,59% | 0,06 Mrd. USD |
| 16 | Federated Hermes Inc | 1,48% | 0,05 Mrd. USD |
| 17 | GSK PLC | 1,38% | 0,05 Mrd. USD |
| 18 | T. Rowe Price Associates, Inc. | 1,36% | 0,05 Mrd. USD |
| 19 | Sofinnova Ventures | 1,17% | 0,04 Mrd. USD |
| 20 | Candriam Luxembourg S.C.A. | 1,15% | 0,04 Mrd. USD |